L. Peterson - Jan 16, 2023 Form 4 Insider Report for TRxADE HEALTH, INC (MEDS)

Role
Director
Signature
/s/ Michael L. Peterson
Stock symbol
MEDS
Transactions as of
Jan 16, 2023
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 03:15 PM
Previous filing
Jan 6, 2023
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDS Common stock Award $0 +100K +527.98% $0.00 119K Jan 16, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDS Stock Option Award $0 +136K $0.00 136K Jan 16, 2023 Common Stock 136K $0.41 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/8th of such shares per quarter (on the first day of each calendar quarter), with the first vesting beginning on April 1, 2023, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer and Chairperson of the Audit Committee. Issued under the Issuer's Amended and Restated 2019 Equity Incentive Plan.
F3 The options vest at the rate of 1/2 of such options per year, on January 4, 2024 and 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.